199
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Drug-Related Problems and Their Predictors Among Patients with Diabetes Attending the Ambulatory Clinic of Gebre Tsadik Shawo General Hospital, Southwest Ethiopia

ORCID Icon & ORCID Icon
Pages 3349-3357 | Published online: 25 Sep 2020

References

  • World Health Organization. Global Report on Diabetes. Geneva: World Health Organization; 2017.
  • Africa international diabetes federation. International Diabetes federationidf.org. Accessed 4 April, 2020.
  • Horvat N, Kos M. Development and validation of the Slovenian drug-related problem classification system based on the PCNE classification version 6.2. Int J Clin Pharm. 2016;38(4):950–959. doi:10.1007/s11096-016-0320-7
  • Pharmaceutical Care Network Europe (PCNE) version 5.01. Classification of drug related problems. May 2006.
  • Cipolle RJ, Strand LM, Morley, PC. Drug Therapy Problems. Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management. 3 ed. McGraw; 2012:156–169.
  • Al-Azzam SI, Alzoubi KH, AbuRuz S, Alefan Q. Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan. Ther Clin Risk Manag. 2016;12:233–239. doi:10.2147/TCRM.S98165
  • Zaman Huri H, Fun Wee H. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC Endocr Disord. 2013;13(1):2. doi:10.1186/1472-6823-13-2
  • Al-Taani GM, Al-Azzam SI, Alzoubi KH, et al. Prediction of drug-related problems in diabetic outpatients in a number of hospitals, using a modeling approach. Drug Healthc Patient Saf. 2017;9:65–70. doi:10.2147/DHPS.S125114
  • Demoz GT, Berha AB, Alebachew Woldu M, Yifter H, Shibeshi W, Engidawork E. Drug therapy problems, medication adherence and treatment satisfaction among diabetic patients on follow-up care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. PLoS One. 2019;14(10):e0222985. doi:10.1371/journal.pone.0222985
  • Argaw AM, Hiwet TTG, Derse BB. Drug therapy problems and determinants among ambulatory type 2 diabetes mellitus patients: pharmacists’ Intervention in South-East Ethiopia. Endocrinol Metab Syndr. 2019;8(04):303. doi:10.35248/2161-1017.19.8.303
  • Lampert ML, Kraehenbuehl S, Hug BL. Drug-related problems: evaluation of a classification system in the daily practice of a Swiss University Hospital. Pharm World Sci. 2008;30(6):768–776. doi:10.1007/s11096-008-9213-8
  • Bp S, Dahal K, Venkataraman P, Uloria R, Chand P. Assessment of clinical pharmacist intervention in tertiary care hospital of India. Asian J Pharm Clin Res. 2013;6(2):258–261.
  • Yimama M, Jarso H, Desse TA. Determinants of drug-related problems among ambulatory type 2 diabetes patients with hypertension comorbidity in Southwest Ethiopia: a prospective cross sectional study. BMC Res Notes. 2018;11(1):679. doi:10.1186/s13104-018-3785-8
  • Koyra HC, Tuka SB, Tufa EG. Epidemiology and predictors of drug therapy problems among type 2 diabetic patients at Wolaita Soddo University Teaching Hospital, Southern Ethiopia. Am J Pharmacol Sci. 2017;5(2):40–48. doi:10.12691/ajps-5-2-4
  • Ayele Y, Melaku K, Dechasa M, et al. Assessment of drug related problems among type 2 diabetes mellitus patients with hypertension in Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia. BMC Res Notes. 2018;11(1):728. doi:10.1186/s13104-018-3838-z
  • S NA H, Syafril S, Syafril S. The effect of drug-related problems on blood glucose level in the treatment of patients with type 2 diabetes mellitus. Open Access Maced J Med Sci. 2019;7(11):1798–1802. doi:10.3889/oamjms.2019.290
  • Sharma A, Baldi A, Sharma DK. Assessment of drug-related problems among diabetes and cardiovascular disease patients in a tertiary care teaching hospital. Pharm Aspire. 2018;10(1):7–12.
  • International Diabetes Federation. IDF Clinical Practice Recommendations for managing type 2 diabetes in primary care. IDF 2017: ISBN: 978-2-930229-85-0.
  • Bjerrum L, Søgaard J, Hallas J, Kragstrup J. Polypharmacy in general practice: differences between practitioners. Br J Gen Pract. 1999;49(440):195–198.
  • MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36(12):3184–3189. doi:10.1097/CCM.0b013e31818f2269
  • Curtis Triplitt P, Drug CDE. Interactions of medications commonly used in diabetes Spectrum. 2006;19(4):202–211. https://doiorg/102337/diaspect194202.
  • May M, Schindler C. Clinically and pharmacologically relevant interactions of antidiabetic drugs. Ther Adv Endocrinol Metab. 2016;7(2):69–83. doi:10.1177/2042018816638050
  • Ogbonna B, Ezenduka CC, Opara CA, Ahara L. Drug therapy problems in patients with type-2 diabetes in a tertiary hospital in Nigeria. Int J Innovat Res Dev. 2014;3:1.
  • Zazuli Z, Rohaya A, Adnyana IK. Drug-related problems in type 2 diabetic patients with hypertension: a prospective study. J Basic Clin Pharma. 2017;8:251–254.